Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-02-20 @ 12:41 PM
Study NCT ID:
NCT01066494
Status:
UNKNOWN
Last Update Posted:
2011-01-17
First Post:
2010-02-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Sponsor:
Antisoma Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AS1413-C-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Fredrik Erlandsson
Old Organization:
Antisoma